Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.